Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-08-16
2049-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis of Hereditary Disorders of Hearing and Balance
NCT00023049
Neurogenetics Patient Registry
NCT02995538
GNAO1 Natural History Study
NCT04950946
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
NCT02450851
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
NCT05589714
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CABP2 participant group
Individuals with hearing impairment who have a molecular genetic diagnosis involving CABP2
Molecular genetic testing and audiometry
Genetic testing and audiometry are the interventions of interest
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Molecular genetic testing and audiometry
Genetic testing and audiometry are the interventions of interest
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Medical Center Goettingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tobias Moser
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tobias Moser, MD
Role: STUDY_DIRECTOR
University Medical Center Goettingen
Bernd Wollnik, MD
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Goettingen
Nicola Strenzke, MD
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Goettingen
Barbara Vona, PhD
Role: PRINCIPAL_INVESTIGATOR
University Medical Center Goettingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Medical Center Goettingen
Göttingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Vona B, Wollnik B, Strenzke N, Pangrsic T, Moser T. Is CABP2-Associated Hearing Loss (DFNB93) a Gene Therapy Target? Preclinical Progress and Patient Registry. MedComm (2020). 2025 Sep 8;6(9):e70363. doi: 10.1002/mco2.70363. eCollection 2025 Sep.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Related Links
Access external resources that provide additional context or updates about the study.
Registry website in English
Registry website in German
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17/8/22 v2.1 - 2023-02528
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.